In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
08 2021
Historique:
received: 21 04 2021
accepted: 11 06 2021
pubmed: 22 6 2021
medline: 11 8 2021
entrez: 21 6 2021
Statut: ppublish

Résumé

Rapidly emerging SARS-CoV-2 variants jeopardize antibody-based countermeasures. Although cell culture experiments have demonstrated a loss of potency of several anti-spike neutralizing antibodies against variant strains of SARS-CoV-2

Identifiants

pubmed: 34153975
doi: 10.1038/s41586-021-03720-y
pii: 10.1038/s41586-021-03720-y
pmc: PMC8349859
mid: NIHMS1718835
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Neutralizing 0
Antibodies, Viral 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Serine Endopeptidases EC 3.4.21.-
HPN protein, human EC 3.4.21.106

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-108

Subventions

Organisme : NIAID NIH HHS
ID : 75N93019C00074
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI095202
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI157155
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI141990
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI151810
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007163
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI152327
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00051
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118938
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

J Immunol. 2020 Aug 15;205(4):915-922
pubmed: 32591393
Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
Nat Med. 2020 Sep;26(9):1422-1427
pubmed: 32651581
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
Immunity. 2021 Jun 8;54(6):1276-1289.e6
pubmed: 33836142
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
N Engl J Med. 2021 Jun 17;384(24):2352-2354
pubmed: 33826819
Science. 2020 Sep 25;369(6511):1603-1607
pubmed: 32732280
Virology. 2020 Sep;548:39-48
pubmed: 32838945
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
J Virol. 2007 Jan;81(2):813-21
pubmed: 17079315
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33211088
Cell Rep Med. 2021 Apr 20;2(4):100255
pubmed: 33842902
Nat Immunol. 2020 Nov;21(11):1327-1335
pubmed: 32839612
Cell. 2021 Apr 1;184(7):1821-1835.e16
pubmed: 33667349
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
N Engl J Med. 2021 Aug 12;385(7):664-666
pubmed: 34233096
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Cell. 2021 Apr 1;184(7):1804-1820.e16
pubmed: 33691139
Nature. 2021 Mar;591(7849):293-299
pubmed: 33494095
Nat Med. 2021 Apr;27(4):620-621
pubmed: 33558724
JAMA. 2021 Feb 16;325(7):632-644
pubmed: 33475701
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Cell Host Microbe. 2021 May 12;29(5):747-751.e4
pubmed: 33887205
Immunity. 2021 Sep 14;54(9):2159-2166.e6
pubmed: 34464596
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Nature. 2020 Dec;588(7838):485-490
pubmed: 33032297
Science. 2020 Nov 20;370(6519):950-957
pubmed: 32972994
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
Mayo Clin Proc. 1988 Feb;63(2):161-74
pubmed: 3276975
Cell Rep. 2021 Mar 23;34(12):108890
pubmed: 33713594
JCI Insight. 2018 Jun 21;3(12):
pubmed: 29925682
Cell Host Microbe. 2021 Apr 14;29(4):551-563.e5
pubmed: 33657424
N Engl J Med. 2021 Mar 11;384(10):905-914
pubmed: 33356051
Nat Rev Immunol. 2021 May;21(5):330-335
pubmed: 33795856
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Nature. 2021 May;593(7857):130-135
pubmed: 33684923

Auteurs

Rita E Chen (RE)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Emma S Winkler (ES)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

James Brett Case (JB)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Ishmael D Aziati (ID)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Traci L Bricker (TL)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Astha Joshi (A)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Tamarand L Darling (TL)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Baoling Ying (B)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

John M Errico (JM)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Swathi Shrihari (S)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Laura A VanBlargan (LA)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Xuping Xie (X)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

Pavlo Gilchuk (P)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Seth J Zost (SJ)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Lindsay Droit (L)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Zhuoming Liu (Z)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Spencer Stumpf (S)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

David Wang (D)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Scott A Handley (SA)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

W Blaine Stine (WB)

AbbVie Bioresearch Center, Worcester, MA, USA.

Pei-Yong Shi (PY)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.

Meredith E Davis-Gardner (ME)

Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.

Mehul S Suthar (MS)

Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.

Miguel Garcia Knight (MG)

Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.

Raul Andino (R)

Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.

Charles Y Chiu (CY)

Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Ali H Ellebedy (AH)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA.

Daved H Fremont (DH)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.

Sean P J Whelan (SPJ)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

James E Crowe (JE)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Lisa Purcell (L)

Vir Biotechnology, St Louis, MO, USA.

Davide Corti (D)

Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.

Adrianus C M Boon (ACM)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Michael S Diamond (MS)

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. diamond@wusm.wustl.edu.
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. diamond@wusm.wustl.edu.
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. diamond@wusm.wustl.edu.
Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA. diamond@wusm.wustl.edu.
Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA. diamond@wusm.wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH